A Retrospective Case-Series Study on Sacral Nerve Stimulation Placement for Bladder and Bowel Dysfunction Among the Pediatric Population

Authors

Elizabeth Redman, MPH(c), RDN, LDN, CNSC, Thomas Jefferson UniversityFollow
Jennifer Hagerty, DO, Nemours A.I. duPont Hospital
John McAna, Phd, MA, Thomas Jefferson University

Document Type

Presentation

Publication Date

6-19-2020

Comments

Presentation: 6:35

Poster attached below.

Abstract

Bladder and bowel dysfunction (BBD) is a common, but likely underdiagnosed, problem among the pediatric population (Santos et al. 2017). BBD can be severe, complicated, and chronic. Sacral Nerve Stimulator (SNS) placement or sacral neuromodulation (SNM) is a potential therapy for BBD when standard, conservative treatments fail. While SNM is an FDA approved treatment option for adults, it remains an off-label and atypical treatment option for the pediatric population. Both short- and long-term research are needed to confirm, refute, or extend findings on SNS among the pediatric population. The objective of this retrospective, case-series research study is to collect and analyze variables associated with SNS placement in order to discern what characteristics or subgroups correspond with positive health outcomes. Additionally, the study aims to report on the usage of an off-label device, Medtronic’s Interstim II Neurostimulator, for the pediatric population. Finally, this retrospective case series study will help generate hypotheses for future prospective studies.It is a descriptive study that collected secondary data on 19 pediatric patients, aged 4 to 21 years old, that received SNS placement from 3/1/2014 to 8/25/2019 at Nemours A.I. duPont Hospital for Children or its Delaware Valley satellite locations. Data were collected using the hospital’s electronic medical record (EMR) system and stored into a data collection tool. Descriptive statistics were used to describe the sample population and overall trends in treatment changes after SNS placement from baseline.

Abstract

Bladder and bowel dysfunction (BBD) is a common, but likely underdiagnosed, problem among the pediatric population (Santos et al. 2017). BBD can be severe, complicated, and chronic. Sacral Nerve Stimulator (SNS) placement or sacral neuromodulation (SNM) is a potential therapy for BBD when standard, conservative treatments fail. While SNM is an FDA approved treatment option for adults, it remains an off-label and atypical treatment option for the pediatric population. Both short- and long-term research are needed to confirm, refute, or extend findings on SNS among the pediatric population. The objective of this retrospective, case-series research study is to collect and analyze variables associated with SNS placement in order to discern what characteristics or subgroups correspond with positive health outcomes. Additionally, the study aims to report on the usage of an off-label device, Medtronic’s Interstim II Neurostimulator, for the pediatric population. Finally, this retrospective case series study will help generate hypotheses for future prospective studies.It is a descriptive study that collected secondary data on 19 pediatric patients, aged 4 to 21 years old, that received SNS placement from 3/1/2014 to 8/25/2019 at Nemours A.I. duPont Hospital for Children or its Delaware Valley satellite locations. Data were collected using the hospital’s electronic medical record (EMR) system and stored into a data collection tool. Descriptive statistics were used to describe the sample population and overall trends in treatment changes after SNS placement from baseline.

Recommended Citation

Redman, MPH(c), RDN, LDN, CNSC, Elizabeth; Hagerty, DO, Jennifer; and McAna, Phd, MA, John, "A Retrospective Case-Series Study on Sacral Nerve Stimulation Placement for Bladder and Bowel Dysfunction Among the Pediatric Population" (2020). Master of Public Health Capstone Presentations. Presentation 322.
https://jdc.jefferson.edu/mphcapstone_presentation/322

Language

English